Veterinary Medicines

Trichoben, lyophilisate and solvent for suspension for injection for cattle

Authorised
  • Trichophyton verrucosum, strain Bodin 1902, Live
Download as PDF

Product identification

Medicine name:
Trichoben, lyophilisate and solvent for suspension for injection for cattle
Trichoben Lyofilisaat en oplosmiddel voor suspensie voor injectie
Trichoben Lyophilisat et solvant pour suspension injectable
Trichoben Lyophilisat und Lösungsmittel zur Herstellung einer Injektionssuspension
Active substance:
  • Trichophyton verrucosum, strain Bodin 1902, Live
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Trichophyton verrucosum, strain Bodin 1902, Live
    6.00
    unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        14
        day
      • Meat and offal
        14
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02A
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:
  • Diluent A is supplied in vials of hydrolytic quality II sealed with rubber stopper and aluminium cap presentation 80 ml in 100-ml vial
  • Diluent A is supplied in vials of hydrolytic quality II sealed with rubber stopper and aluminium cap presentation 10 ml in 10-ml vial
  • Diluent A is supplied in vials of hydrolytic quality I sealed with rubber stopper and aluminium cap resentation 40 ml in 50-ml vial
  • Diluent A is supplied in vials of hydrolytic quality I sealed with rubber stopper and aluminium cap presentation 80 ml in 100-ml vial
  • Diluent A is supplied in vials of hydrolytic quality I sealed with rubber stopper and aluminium cap presentation 10 ml in 10-ml vial
  • Vaccine is supplied in the freeze-dried state in 10-ml vials, hydrolytic quality I, sealed with rubber stopper and aluminium cap
  • Vaccine is supplied in the freeze-dried state in 10-ml vials, hydrolytic quality I, sealed with rubber stopper and aluminium Flip off
  • Diluent A is supplied in vials of hydrolytic quality II sealed with rubber stopper and aluminium cap resentation 40 ml in 50-ml vial
  • Carton box containing 1 x 40 ml (after reconstitution) and corresponding amounts of Diluent A
  • Carton box containing 5 x 10 ml (after reconstitution) and corresponding amounts of Diluent A
  • Carton box containing 1 x 80 ml (after reconstitution) and corresponding amounts of Diluent A

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Kernfarm B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0233/001
Concerned member states:
  • Belgium

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download